These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7011157)

  • 1. [Bismuth salts used in gastro-enterology. Data from animal investigations (author's transl)].
    Bouvet P
    Ann Pharm Fr; 1981 Feb; 38(5):447-54. PubMed ID: 7011157
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research conducted by INSERM on myoclonic encephalopathies induced by the insoluble salts of bismuth used in gastroenterology].
    Olive G
    Therapie; 1980; 35(3):305-6. PubMed ID: 6775384
    [No Abstract]   [Full Text] [Related]  

  • 3. [The bismuth-encephalopathy - a new pathological syndrome (author's transl)].
    Eichler I
    Wien Klin Wochenschr; 1979 Apr; 91(9):314-20. PubMed ID: 109997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute fatal encephalopathy with osteonecrosis of both humeral heads following the ingestion of minimal doses of insoluble bismuth salts (author's transl)].
    Lhermitte F; Mallecourt J; Chedru F; Kuperwasser B; Glaser P
    Nouv Presse Med; 1978 Jun; 7(24):2170-1. PubMed ID: 683868
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myoclonic encephalopathy due to ingestion of insoluble salts of bismuth].
    Cambier J; Dairou R
    Arch Fr Mal App Dig; 1975; 64(1):5-9. PubMed ID: 1164144
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bismuth encephalopathies outside France (author's transl)].
    Lagier G
    Therapie; 1980; 35(3):315-7. PubMed ID: 7423419
    [No Abstract]   [Full Text] [Related]  

  • 7. [Humeral head necrosis during bismuth encephalopathy (author's transl)].
    Mabille JP; Gaudet M; Charpin JF
    Ann Radiol (Paris); 1980; 23(6):515-7. PubMed ID: 7436320
    [No Abstract]   [Full Text] [Related]  

  • 8. [Psychiatric aspects of encephalopathy caused by bismuth salts].
    Bertaud M; Mangin P; Charlin A
    Ann Med Psychol (Paris); 1976 May; 1(5):717-21. PubMed ID: 970827
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epidemiological aspects of the encephalopathies resulting from oral administration of bismuth (author's transl)].
    Martin-Bouyer G; Foulon B; Guerbois H; Barin C
    Therapie; 1980; 35(3):307-13. PubMed ID: 7423418
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bismuth encephalopathy: a reappraisal of risk factors].
    Lechat P; Kisch R
    Gastroenterol Clin Biol; 1986; 10(8-9):562-9. PubMed ID: 3536650
    [No Abstract]   [Full Text] [Related]  

  • 11. [Letter: Encephalopathies due to insoluble salts of bismuth].
    Goule JP; Husson A; Fondimare A; Rapoport F; Lebreton M; Lajarige V
    Nouv Presse Med; 1975 May; 4(18):1366. PubMed ID: 1153303
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bismuth treatment and blood bismuth levels].
    Hillemand P; Pallière M; Laquais B; Bouvet P
    Sem Hop; 1977 Sep; 53(31-32):1663-9. PubMed ID: 198893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warning against products containing bismuth subsalicylate.
    Henderson IW
    Can Med Assoc J; 1980 Nov; 123(9):848. PubMed ID: 7437988
    [No Abstract]   [Full Text] [Related]  

  • 14. [The intracerebral distribution of bismuth in bismuth encephalopathy. Pathological and toxicological study of 3 cases (author's transl)].
    Ribadeau Dumas JL; Lechevalier B; Breteau M; Allain Y
    Nouv Presse Med; 1978 Dec; 7(44):4021-5. PubMed ID: 733570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Humeral head necrosis during bismuth encephalopathy (author's transl)].
    Mabille JP; Gaudet M; Charpin JF
    Sem Hop; 1981 Feb 18-25; 57(7-8):389-91. PubMed ID: 6261377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the bismuth effect on bacteria, specially on faecal flora (author's transl)].
    Joly B; Petit S; Laveran H; Cluzel R
    Ann Pharm Fr; 1980; 38(1):75-80. PubMed ID: 7396344
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possible part of intestinal flora in bismuth intoxications (author's transl)].
    Martin-Bouyer G; Nevot P; Singlas E; Foulon G; Philippon A; Duret M; Fievet MH; Clavel JP; Simon P
    Therapie; 1981; 36(4):483-8. PubMed ID: 7292433
    [No Abstract]   [Full Text] [Related]  

  • 18. [Myoclonic bismuth-induced encephalopathy. Case report (author's transl)].
    Loseke N; Retif J; Coune A; Soebert A; Molle L; D'haens J
    Acta Gastroenterol Belg; 1978; 41(1-2):72-80. PubMed ID: 665114
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advantages and disadvantages of bismuth salts in digestive therapy].
    Maison E
    Med Chir Dig; 1977; 6(3):167-70. PubMed ID: 895245
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myoclonic encephalopathies induced by bismuth salts. 6 cases observed during long-term oral treatment].
    Buge A; Rancurel G; Poisson M; Dechy H
    Nouv Presse Med; 1974 Oct; 3(36):2315-20. PubMed ID: 4218313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.